Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat.
The cardioprotective effects of short-term exercise against myocardial ischaemia-reperfusion injury in male and female rats were examined. We subjected male and female rats to 0 (Sed; n = 8 males and 8 females), 1 (1 day; n = 10 males and 8 females), or 5 (5 day; n = 6 males and 6 females) days of treadmill running. Langendorff-perfused hearts underwent 1 h of regional ischaemia and 2 h of reperfusion, and infarct size (expressed as a percentage of the zone at risk; ZAR), left ventricular pressure development, and coronary flow were measured for each heart. Preischaemic pressure development and coronary flow did not differ between the sexes nor were they influenced by exercise. Sed females had significantly smaller infarct sizes (25 +/- 3%) than Sed male hearts (37 +/- 3%; P < 0.001). Short-term running significantly reduced infarct size following 1 day (27 +/- 3%; P < 0.05) and 5 days (30 +/- 4%; P < 0.10) of exercise in males. One day of running did not reduce infarct size in females (19 +/- 3%; P = NS), but 5 day females did show a significant reduction in infarct size (13 +/- 2%; P < 0.05). There was no relationship between postischaemic coronary vascular hyperaemia and infarct size across sexes or exercise training groups. Hearts from Sed females exhibited significantly higher manganese superoxide dismutase (MnSOD) protein expression than hearts from Sed males, but short-term exercise (neither 1 nor 5 days) did not alter MnSOD protein in either sex. Increased sarcolemmal ATP-sensitive K(+) (K(ATP)) channel subunit protein expression (SUR2A and/or K(ir)6.2) correlated closely with sex-dependent and exercise-acquired protection against myocardial infarction. These data indicate that: (1) sex-dependent and exercise-induced differences in the susceptibility of the heart to ischaemia-reperfusion injury are not associated with improved coronary flow or postischaemic hyperaemia; (2) increased MnSOD protein expression is not necessary for exercise-induced protection from infarction; and (3) one possible mechanism for sex-dependent and exercise-mediated reductions in infarct size involves an increased protein expression of cardiac sarcolemmal K(ATP) channels.
Brown
David A
DA
Department of Integrative Physiology, University of Colorado Cardiovascular Institute, University of Colorado at Boulder, Boulder, CO 80309-0354, USA.
Lynch
Joshua M
JM
Armstrong
Casey J
CJ
Caruso
Nicholas M
NM
Ehlers
Lindsay B
LB
Johnson
Micah S
MS
Moore
Russell L
RL
D000818:Animals; D004198:Disease Susceptibility / Q000503:physiopathology; D005260:Female; D008297:Male; D015428:Myocardial Reperfusion Injury / Q000235:genetics / Q000378:metabolism* / Q000517:prevention & control*; D010805:Physical Conditioning, Animal / Q000379:methods / Q000502:physiology*; D024661:Potassium Channels, Inwardly Rectifying / Q000096:biosynthesis / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D012727:Sex Characteristics; D013482:Superoxide Dismutase / Q000096:biosynthesis / Q000235:genetics; D000099161:Kcnj11 Channel
D024661:Potassium Channels, Inwardly Rectifying; D013482:Superoxide Dismutase; D000099161:Kcnj11 Channel
Circulation. 2000 Jun 20;101(24):2841-8
10859291
Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H2106-13
12598229
Am J Physiol. 1998 Nov;275(5 Pt 2):R1468-77
9791063
Circ Res. 1992 Feb;70(2):223-33
1310443
J Exp Med. 1999 Jun 7;189(11):1699-706
10359573
Science. 1995 Nov 17;270(5239):1166-70
7502040
Med Sci Sports Exerc. 1998 Mar;30(3):352-60
9526880
Circ Res. 2002 May 3;90(8):911-7
11988493
Braz J Med Biol Res. 2002 Sep;35(9):1075-81
12219179
J Am Coll Cardiol. 2001 Sep;38(3):906-15
11527652
Lancet. 1980 Dec 6;2(8206):1207-10
6108391
Physiol Rev. 2003 Oct;83(4):1113-51
14506302
Circulation. 2000 Jul 25;102(4):452-7
10908219
Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H921-30
12915383
J Appl Physiol (1985). 1994 Apr;76(4):1608-14
8045839
Circ Res. 2001 Aug 3;89(3):273-8
11485978
Am J Physiol Heart Circ Physiol. 2003 Jul;285(1):H347-51
12649077
J Thromb Thrombolysis. 1995;2(3):221-225
10608027
J Appl Physiol (1985). 2002 Apr;92(4):1473-9
11896012
Life Sci. 1997;60(6):391-6
9031685
J Appl Physiol (1985). 2003 Dec;95(6):2510-8
12937028
Eur J Pharmacol. 2003 Apr 25;467(1-3):163-8
12706470
Circ Res. 2000 Nov 10;87(10):845-55
11073879
Am J Physiol. 1992 Sep;263(3 Pt 2):H804-9
1415606
Circ Res. 2000 Nov 24;87(11):972-83
11090541
Cardiovasc Drugs Ther. 1998 Oct;12(5):457-62
9926276
J Cardiovasc Pharmacol. 1993 Jul;22(1):65-8
7690098
Heart. 2001 Mar;85(3):331-6
11179278
Am Heart J. 1995 Jun;129(6):1108-13
7754940
J Appl Physiol (1985). 2003 Jul;95(1):250-64
12626483
J Appl Physiol (1985). 2001 Oct;91(4):1545-54
11568135
Am J Physiol Heart Circ Physiol. 2001 Sep;281(3):H1346-52
11514306
Am J Physiol Heart Circ Physiol. 2000 Apr;278(4):H1030-4
10749694
FASEB J. 1998 May;12(7):523-9
9576479
J Mol Cell Cardiol. 2000 Jul;32(7):1147-58
10860759
Arq Bras Cardiol. 2002 Apr;78(4):392-5
12011955
J Appl Physiol (1985). 2001 Nov;91(5):2205-12
11641363
J Appl Physiol (1985). 2003 Jan;94(1):234-44
12391095
Free Radic Biol Med. 2003 Apr 1;34(7):800-9
12654467